PDT Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-46,758
| Closed | -$127K | – | 905 |
|
|
2022
Q3 | $127K | Sell |
46,758
-35,481
| -43% | -$96.4K | 0.02% | 769 |
|
|
2022
Q2 | $238K | Hold |
82,239
| – | – | 0.02% | 793 |
|
|
2022
Q1 | $247K | Sell |
82,239
-54,076
| -40% | -$162K | 0.02% | 774 |
|
|
2021
Q4 | $627K | Buy |
136,315
+32,372
| +31% | +$149K | 0.05% | 476 |
|
|
2021
Q3 | $653K | Sell |
103,943
-33,300
| -24% | -$209K | 0.05% | 416 |
|
|
2021
Q2 | $822K | Buy |
137,243
+94,948
| +224% | +$569K | 0.05% | 408 |
|
|
2021
Q1 | $268K | Buy |
+42,295
| New | +$268K | 0.02% | 647 |
|
|
2020
Q4 | – | Sell |
-48,294
| Closed | -$281K | – | 863 |
|
|
2020
Q3 | $281K | Buy |
+48,294
| New | +$281K | 0.02% | 559 |
|
|
2020
Q1 | – | Sell |
-32,329
| Closed | -$259K | – | 870 |
|
|
2019
Q4 | $259K | Buy |
+32,329
| New | +$259K | 0.02% | 581 |
|